Compagnie Lebon operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Compagnie Lebon with three other
financial institutions in Europe:
DeA Capital S.p.A.
sales of 64.45 million Euro [US$73.07 million]
MedCap AB (publ)
(799.94 million Swedish Kronor [US$87.48 million]
of which 40%
was Medical Technology), and
based in Sweden
(689.60 million Swedish Kronor [US$75.41 million]
of which 100%
was Investment Activities).
During the year ended December of 2017, sales at
Compagnie Lebon were 77.38 million Euro (US$87.73 million).
decrease of 36.4%
versus 2016, when the company's sales were 121.67 million Euro.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Compagnie Lebon had sales
of 85.57 million Euro.
Contributing to the drop in overall sales was the 74.2% decline
in Property-Real Estate, from 59.16 million Euro to 15.24 million Euro.
There were also decreases in sales in
Holding and Other (down 5.5% to 2.56 million Euro)
However, these declines were partially offset by the increase in sales of
Hotel Sector (up 3.9% to 46.82 million Euro)
Financial Sector (up 592.7% to 762,000.00 Euro)